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1. Introduction 
The therapeutic use of aminoglycoside antibiotics 
is frequently hampered by the occurrence of resistant 
bacteria which contain plasmid-mediated inactivating 
enzymes [l-3] . Among clinical isolates of bacteria 
resistant to gentamicin, acetylation of the 3-NH2 
group of the deoxystreptamine moiety is a widespread 
type of modification [4,5] . Aminoglycoside acetyl- 
transferases (3) isolated from various sources form 
distinct groups characterized by differences in sub- 
strate range and physical properties [6-81 . The 
enzyme mediated by plasmid RIP 135 [9] , for 
example, can modify gentamicin but not tobramycin 
or neomycin, whereas the enzyme from Pseudomonas 
aeruginosa PST can inactivate all these antibiotics. 
It is not known whether enzymes with different sub- 
strate specificities have evolved from one enzyme by 
mutational alteration, if they are derived from a 
common bacterial origin, or if they are the products 
of unrelated genes. 
We have been investigating the evolutionary origin 
and extent of transfer of aminoglycoside modifying 
enzymes. Unfortunately, the difficulties encountered 
in purifying the acetyltransferases, in particular their 
instability, make it improbable that the substantial 
quantities of homogeneous enzymes necessary for 
complete amino acid sequence determinations will 
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be obtained. However, the gene coding for the amino- 
glycoside acetyltransferase(3)-I mediated by plasmid 
RIP 135 has recently been cloned onto the colicin El 
plasmid (Haas, M. J., unpublished), and it is now 
feasible to determine its DNA sequence. We report 
here the NH2-terminal sequence of AAC(3)-I in order 
to (1) facilitate locating the origin of the nucleic acid 
sequence which codes for its structural gene, and (2) 
probe its relationship to the acetyltransferases which 
modify the 6’-NH2 and 2’-NH2 groups of amino- 
glycosides [3,1 I-131. 
2. Materials and methods 
AAC(3)-I, a tetrameric protein of 63 000 molecular 
weight [lo] , isolated from E. coli RIP 135/C600 was 
a gift of J. W. Williams, D. B. Northrop and M. J. Haas. 
Twelve milligrams dry weight of purified enzyme 
were reduced and carboxymethylated as described 
[ 141 , except guanidine hydrochloride (5 M) was used 
instead of 8 M urea. Dansyl amino terminal identifica- 
tion was carried out as described [ 151 . 
Amino acid sequence analysis was performed using 
a Beckman automatic sequencer 890 C and the 
Beckman DMAA peptide program in the laboratory 
of R. D. Cole. Identification of PTH-amino acids was 
carried out by (1) gas-liquid chromatography [ 161 on 
a Varian gas chromatograph 1840 A; (2) high-pressure 
liquid chromatography [ 171 on a Waters Associates 
liquid chromatograph with a PBondapak C 18 column; 
(3) amino acid analysis after HI hydrolysis [ 181 on a 
Beckman 121 automatic amino acid analyzer. 
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3. Results and discussion Acknowledgments 
The amino acid composition of RCM-AAC(3)-I 
agreed with published values [lo] . Dansyl N-terminal 
analysis of the preparation gave a spot corresponding 
to methionine sulfone. 
One hundred and thirteen nanomoles of RCM- 
AAC(3)-I were sequenced through 40 cycles in a 
single run using the automatic sequencer. The sequence 
of the NH,-terminal 21 residues is shown in fig.1. The 
yield of leucine at the nineteenth cycle was approx- 
imately 14 nmol. Residue 14 could not be identified 
by any of the three methods used; we could not 
eliminate the possibility that it was methionine or 
tryptophan. 
The partial sequence reported here is the first 
sequence determination of an aminoglycoside modify- 
ing enzyme. Comparison of the AAC(3)-I sequence 
with NH2-terminal published data on several plasmid- 
mediated chloramphenicol acetyltransferases [ 191 
and carbohydrate binding proteins [20] did not 
uncover evidence of any sequence resemblance. 
Immunological studies using antiserum to AAC(3)-I 
indicated that it shares some homology with other 
plasmid-mediated 3-N-acetyltransferases of narrow 
substrate specificity (e.g. R1033 from P. aerrtginosa 
[2 l] ) and with the 2’-NHz aminoglycoside acetyl- 
transferases (White, T. J., unpublished; [3]). How- 
ever, no immunological cross-reactivity could be 
detected between AAC(3)-I and either: the AAC(3) 
enzymes having a broader substrate specificity or the 
6’-NH2 acetyltransferases (Haas,M. J. and White, T. J., 
unpublished). Additional sequence studies at the 
protein and nucleic acid level will be necessary to 
understand the evolutionary relationships among 
these diverse inactivating enzymes. 
I 5 
Met-Leu-Arg-Ser-Ser- 
A%-Asp-“ol-Thr-G% 
II 15 
Gln-Gly-Alo- X -Pro- 
I6 20 
Lys - Thr - Lys - Leu - Gly - Gly- 
Fig.1. NH,-terminal sequence of aminoglycoside acetyl- 
transferase(3)-I mediated by plasmid RIP 135. 
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